Advanced Automated Cell Cryopreservation Technology

Current methods for cryopreserving cells through vitrification rely on manual procedures, which are time-consuming, labor-intensive, and prone to human error. The original patent addressed this issue with a device for automated permeation, but its limitations in terms of precision, efficiency, and adaptability to different cell types and cryoprotectant concentrations remain. This new invention overcomes these limitations by integrating advanced technologies to create a more efficient, accurate, and customizable permeation process.

The new claims introduce a paradigm shift in cryopreservation technology by integrating robotics, artificial intelligence, and microfluidics to create a highly efficient, adaptable, and precise permeation process. The use of machine learning algorithms to optimize permeation protocols, electroporation to enhance cryoprotectant uptake, and interchangeable cartridges for customized protocols are all novel and non-obvious advancements over the original patent.

Alternative embodiments of the invention could include the use of other types of automation, such as pneumatic or hydraulic systems, or the integration of additional sensors and monitoring systems to further optimize the permeation process. Variations of the invention could also include the use of different types of cryoprotectant agents, or the application of the technology to other types of biological materials.

The advanced system for automated permeation of biological materials has significant commercial potential in the fields of regenerative medicine, biobanking, and cryopreservation. The technology could be used to improve the efficiency and accuracy of cryopreservation processes, leading to increased adoption and market growth. Potential target industries include pharmaceutical companies, research institutions, and biotechnology companies.